{"transactions":[{"id":917713,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":1,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":2,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":3,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":4,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44676,"kind":"person","name":"Alex Slanix Paul","position":5,"cik":"0002092283","reported_name":"Alex Slanix Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-02-06T00:00:01.000Z","date":"2026-02-03","kind":"purchase","planned":false,"acquired":true,"shares":700741,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Warrants were purchased together with the Common Shares reported herein for an aggregate purchase price of $12.13 per Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The warrants to purchase Common Shares (the \"Warrants\") are exercisable immediately and will expire upon the earlier of (i) within 60 days of the Milestone Event or (ii) February 3, 2031. For purposes of the foregoing, the \"Milestone Event\" means the public announcement via press release or the filing of a Current Report on Form 8-K by the Issuer of topline data from the cohorts treated with single ascending doses of PMN310."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The warrants to purchase Common Shares (the \"Warrants\") are exercisable immediately and will expire upon the earlier of (i) within 60 days of the Milestone Event or (ii) February 3, 2031. For purposes of the foregoing, the \"Milestone Event\" means the public announcement via press release or the filing of a Current Report on Form 8-K by the Issuer of topline data from the cohorts treated with single ascending doses of PMN310."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Fan Yu is the controlling stockholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages the investments of Ally Bridge MedAlpha Master Fund L.P. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by Ally Bridge MedAlpha Master Fund L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Fan Yu is also the indirect controlling stockholder of ABG Global Life Science Capital Partners V GP Limited, which is the general partner of ABG Global Life Science Capital Partners V GP, L.P., which is the general partner of Ally Bridge Group Global Life Science Capital Partners V, L.P., which is the controlling shareholder of ABG V-SIV IX Limited. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by ABG V-SIV IX Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Fan Yu is also the controlling stockholder of ABG V-SIV X Limited. As such, Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by ABG V-SIV X Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The Warrants reported herein include: (i) Warrants to purchase 164,881 Common Shares held of record by Ally Bridge MedAlpha Master Fund L.P., (ii) Warrants to purchase 329,760 Common Shares held of record by ABG V-SIV IX Limited and (iii) Warrants to purchase 206,100 Common Shares held of record by ABG V-SIV X Limited."}],"balance_after":700741,"derivative":{"exercise_price":14.4,"underlying":"Common Shares","underlying_shares":700741},"source":{"system":"sec-edgar","filing":"0001493152-26-005410","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668029/000149315226005410/ownership.xml","form_type":"4"}},{"id":917712,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":1,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":2,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":3,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":4,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44676,"kind":"person","name":"Alex Slanix Paul","position":5,"cik":"0002092283","reported_name":"Alex Slanix Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-02-06T00:00:01.000Z","date":"2026-02-03","kind":"purchase","planned":false,"acquired":true,"shares":700741,"price":12.13,"value":8499988.33,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Warrants were purchased together with the Common Shares reported herein for an aggregate purchase price of $12.13 per Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Common Shares reported herein include: (i) 407,230 Common Shares held of record by Ally Bridge MedAlpha Master Fund L.P., (ii) 329,760 Common Shares held of record by ABG V-SIV IX Limited and (iii) 206,100 Common Shares held of record by ABG V-SIV X Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Fan Yu is the controlling stockholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages the investments of Ally Bridge MedAlpha Master Fund L.P. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by Ally Bridge MedAlpha Master Fund L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Fan Yu is also the indirect controlling stockholder of ABG Global Life Science Capital Partners V GP Limited, which is the general partner of ABG Global Life Science Capital Partners V GP, L.P., which is the general partner of Ally Bridge Group Global Life Science Capital Partners V, L.P., which is the controlling shareholder of ABG V-SIV IX Limited. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by ABG V-SIV IX Limited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Fan Yu is also the controlling stockholder of ABG V-SIV X Limited. As such, Mr. Fan Yu may be deemed to share beneficial ownership of the securities held of record by ABG V-SIV X Limited."}],"balance_after":943090,"source":{"system":"sec-edgar","filing":"0001493152-26-005410","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668029/000149315226005410/ownership.xml","form_type":"4"}},{"id":1013832,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":1,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":2,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":3,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":4,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44676,"kind":"person","name":"Alex Slanix Paul","position":5,"cik":"0002092283","reported_name":"Alex Slanix Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-10-24T20:34:08.000Z","date":"2025-10-22","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option vested on the date of grant and the remaining shares shall vest in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This option was granted to Slanix Alex, a director of the Issuer and an employee of Ally Bridge Group (NY) LLC, which manages the investments of Ally Bridge MedAlpha Master Fund L.P. Dr. Alex holds any equity-based compensation awarded to him for his service as a director of the Issuer for the benefit of Ally Bridge MedAlpha Master Fund L.P. Any proceeds from the sale of shares upon exercise of this award shall be remitted to Ally Bridge MedAlpha Master Fund L.P. The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such securities are beneficially owned by him for Section 16 or any other purpose."}],"balance_after":40000,"derivative":{"exercise_price":0.45,"expiration_date":"2035-10-22","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-25-019320","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668029/000149315225019320/ownership.xml","form_type":"4"}},{"id":1847938,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Warrant (Right to Buy)","published_at":"2023-06-21T16:05:12.000Z","date":"2023-06-16","kind":"other","planned":false,"acquired":true,"shares":965130,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by MedAlpha. Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":965130,"derivative":{"exercise_price":0.3854,"exercise_date":"2023-06-16","expiration_date":"2028-06-16","underlying":"Common Stock","underlying_shares":965130},"source":{"system":"sec-edgar","filing":"0000899243-23-016125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323016125/doc4.xml","form_type":"4"}},{"id":1847937,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Warrant (Right to Buy)","published_at":"2023-06-21T16:05:12.000Z","date":"2023-06-16","kind":"other","planned":false,"acquired":true,"shares":6818181,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the \"2023 Securities Purchase Agreement\"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited (\"ABG WTT\") and Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT. ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":6818181,"derivative":{"exercise_price":0.3854,"exercise_date":"2023-06-16","expiration_date":"2028-06-16","underlying":"Common Stock","underlying_shares":6818181},"source":{"system":"sec-edgar","filing":"0000899243-23-016125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323016125/doc4.xml","form_type":"4"}},{"id":1952323,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant (Right to Buy)","published_at":"2023-03-15T16:30:12.000Z","date":"2023-03-13","kind":"purchase","acquired":true,"shares":965130,"price":0.3212,"value":309999.756,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Prior to the Issuer receiving certain required approval of the Issuer's stockholders (the \"Requisite Stockholder Approval\"), the Pre-Funded Warrant holders may only exercise up to the product of (i) the holder's pro rata portion of the Pre-Funded Warrants and (ii) 16,025,925, which is the number of shares equal to 19.99% of the Issuer's Common Stock outstanding on March 9, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":965130,"derivative":{"exercise_price":0.001,"exercise_date":"2023-03-13","underlying":"Common Stock","underlying_shares":965130},"source":{"system":"sec-edgar","filing":"0000899243-23-008565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323008565/doc4.xml","form_type":"4"}},{"id":1952322,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant (Right to Buy)","published_at":"2023-03-15T16:30:12.000Z","date":"2023-03-13","kind":"purchase","acquired":true,"shares":6818181,"price":0.3212,"value":2189999.7372,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Prior to the Issuer receiving certain required approval of the Issuer's stockholders (the \"Requisite Stockholder Approval\"), the Pre-Funded Warrant holders may only exercise up to the product of (i) the holder's pro rata portion of the Pre-Funded Warrants and (ii) 16,025,925, which is the number of shares equal to 19.99% of the Issuer's Common Stock outstanding on March 9, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":6818181,"derivative":{"exercise_price":0.001,"exercise_date":"2023-03-13","underlying":"Common Stock","underlying_shares":6818181},"source":{"system":"sec-edgar","filing":"0000899243-23-008565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924323008565/doc4.xml","form_type":"4"}},{"id":2302652,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":1487058,"price":1.0625,"value":1579999.125,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership.\n\nAs a result of an internal reorganization, Ally Bridge MedAlpha Management L.P. and Ally Bridge MedAlpha Management GP, LLC are no longer deemed to share beneficial ownership of the securities reported herein."}],"balance_after":1487058,"derivative":{"exercise_price":1.25,"exercise_date":"2022-04-04","expiration_date":"2027-04-04","underlying":"Common Stock","underlying_shares":1487058},"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2302651,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":5571764,"price":1.0625,"value":5919999.25,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":5571764,"derivative":{"exercise_price":1.25,"exercise_date":"2022-04-04","expiration_date":"2027-04-04","underlying":"Common Stock","underlying_shares":5571764},"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2302650,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":2974117,"price":1.0625,"value":3159999.3125,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership.\n\nAs a result of an internal reorganization, Ally Bridge MedAlpha Management L.P. and Ally Bridge MedAlpha Management GP, LLC are no longer deemed to share beneficial ownership of the securities reported herein."}],"balance_after":5894897,"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2302649,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":8,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T16:30:30.000Z","date":"2022-04-04","kind":"purchase","acquired":true,"shares":11143529,"price":1.0625,"value":11839999.5625,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":15029480,"source":{"system":"sec-edgar","filing":"0000899243-22-014088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924322014088/doc4.xml","form_type":"4"}},{"id":2921422,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T16:31:34.000Z","date":"2020-12-31","kind":"purchase","acquired":true,"shares":5727,"price":14.9959,"value":85881.5193,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.83 to $15.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2920780,"source":{"system":"sec-edgar","filing":"0000899243-21-000379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924321000379/doc4.xml","form_type":"4"}},{"id":2921421,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T16:31:34.000Z","date":"2020-12-31","kind":"purchase","acquired":true,"shares":6943,"price":14.9959,"value":104116.5337,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.83 to $15.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3885951,"source":{"system":"sec-edgar","filing":"0000899243-21-000379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924321000379/doc4.xml","form_type":"4"}},{"id":2929005,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-29","kind":"purchase","acquired":true,"shares":45,"price":14,"value":630.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2915053,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2929004,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-29","kind":"purchase","acquired":true,"shares":55,"price":14,"value":770.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3879008,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2929003,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-28","kind":"purchase","acquired":true,"shares":3213,"price":13.9766,"value":44906.8158,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.85 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2915008,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2929002,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-30T16:30:17.000Z","date":"2020-12-28","kind":"purchase","acquired":true,"shares":3894,"price":13.9766,"value":54424.8804,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.85 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3878953,"source":{"system":"sec-edgar","filing":"0000899243-20-035506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035506/doc4.xml","form_type":"4"}},{"id":2931547,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-24","kind":"purchase","acquired":true,"shares":4019,"price":13.9919,"value":56233.4461,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.90 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2911795,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931546,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-24","kind":"purchase","acquired":true,"shares":4871,"price":13.9919,"value":68154.5449,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.90 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3875059,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931545,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-23","kind":"purchase","acquired":true,"shares":9810,"price":13.9865,"value":137207.565,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.91 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2907776,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931544,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-23","kind":"purchase","acquired":true,"shares":11890,"price":13.9865,"value":166299.485,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.91 to $14.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3870188,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931543,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-22","kind":"purchase","acquired":true,"shares":7661,"price":13.7016,"value":104967.9576,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.96. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2897966,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2931542,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-28T16:30:26.000Z","date":"2020-12-22","kind":"purchase","acquired":true,"shares":9287,"price":13.7016,"value":127246.7592,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.45 to $13.96. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3858298,"source":{"system":"sec-edgar","filing":"0000899243-20-035198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320035198/doc4.xml","form_type":"4"}},{"id":2934961,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-21","kind":"purchase","acquired":true,"shares":7358,"price":13.3147,"value":97969.5626,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2890305,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2934960,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-21","kind":"purchase","acquired":true,"shares":8919,"price":13.3147,"value":118753.8093,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3849011,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2934959,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-18","kind":"purchase","acquired":true,"shares":8408,"price":13.5946,"value":114303.3968,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.38 to $13.84. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2882947,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2934958,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-22T16:30:55.000Z","date":"2020-12-18","kind":"purchase","acquired":true,"shares":10192,"price":13.5946,"value":138556.1632,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.38 to $13.84. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3840092,"source":{"system":"sec-edgar","filing":"0000899243-20-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034836/doc4.xml","form_type":"4"}},{"id":2938127,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":1029,"price":14,"value":14406.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2874539,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938126,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":1248,"price":14,"value":17472.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3829900,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938125,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":5731,"price":13.1201,"value":75191.2931,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.99 to $13.99. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2873510,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938124,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-17","kind":"purchase","acquired":true,"shares":6946,"price":13.1201,"value":91132.2146,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.99 to $13.99. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3828652,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938123,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-16","kind":"purchase","acquired":true,"shares":12851,"price":13.0611,"value":167848.1961,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.20. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2867779,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2938122,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T16:30:10.000Z","date":"2020-12-16","kind":"purchase","acquired":true,"shares":15578,"price":13.0611,"value":203465.8158,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.20. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3821706,"source":{"system":"sec-edgar","filing":"0000899243-20-034482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034482/doc4.xml","form_type":"4"}},{"id":2942885,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":9027,"price":13.0821,"value":118092.1167,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.38. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2854928,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942884,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":10942,"price":13.0821,"value":143144.3382,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.38. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3806128,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942883,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":4276,"price":12.4955,"value":53430.758,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.29 to $12.995. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2845901,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942882,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":5184,"price":12.4955,"value":64776.672,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.29 to $12.995. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3795186,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942881,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-14","kind":"purchase","acquired":true,"shares":6535,"price":12.2443,"value":80016.5005,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.0125 to $12.62. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. (\"MedAlpha\"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of each of Ally Bridge MedAlpha Management GP, LLC and Ally Bridge Group (NY) LLC. Ally Bridge Group (NY) LLC and Ally Bridge MedAlpha Management L.P., acting through its general partner Ally Bridge MedAlpha Management GP, LLC, manage MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership."}],"balance_after":2841625,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}},{"id":2942880,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":112061,"kind":"organization","name":"ABG WTT-MedAvail Ltd","position":1,"cik":"0001832110","reported_name":"ABG WTT-MedAvail Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112062,"kind":"organization","name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","position":2,"cik":"0001808684","reported_name":"Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112063,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","position":3,"cik":"0001832109","reported_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":96826,"kind":"organization","name":"ABG-WTT Global Life Science Capital Partners GP Ltd","position":4,"cik":"0001832108","reported_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67584,"kind":"organization","name":"ABG Management Ltd.","position":5,"cik":"0001832106","reported_name":"ABG Management Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67587,"kind":"person","name":"Yu Fan","position":6,"cik":"0001668029","reported_name":"Yu Fan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67585,"kind":"organization","name":"Ally Bridge MedAlpha Master Fund L.P.","position":7,"cik":"0001831963","reported_name":"Ally Bridge MedAlpha Master Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144149,"kind":"organization","name":"Ally Bridge MedAlpha Management L.P.","position":8,"cik":"0001766516","reported_name":"Ally Bridge MedAlpha Management L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144150,"kind":"organization","name":"Ally Bridge MedAlpha Management GP, LLC","position":9,"cik":"0001832107","reported_name":"Ally Bridge MedAlpha Management GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67586,"kind":"organization","name":"Ally Bridge Group (NY) LLC","position":10,"cik":"0001822947","reported_name":"Ally Bridge Group (NY) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T21:00:08.000Z","date":"2020-12-14","kind":"purchase","acquired":true,"shares":7922,"price":12.2443,"value":96999.3446,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.0125 to $12.62. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by ABG WTT-MedAvail Limited (\"ABG WTT\"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership."}],"balance_after":3790002,"source":{"system":"sec-edgar","filing":"0000899243-20-034209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808684/000089924320034209/doc4.xml","form_type":"4"}}]}